Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Pacemaker Co. Seeks Clarity on Qui Tam Publicity Test No Photo Available

Dan McKay

A medical device company is asking the U.S. Supreme Court to clarify the False Claims Act's public disclosure bar. To succeed, the com... (more story)

Healthcare Deals This Week: Novartis, Sanofi, Gilead No Photo Available

Yeji Jesse Lee

Alphabet's mega-round and major agreements in the T-cell engager space. Law360 breaks down the big deals from the past week.

Utah Hospitals To Track Violence As States Step Up Reporting No Photo Available

Dan McKay

Under a new law, Utah hospitals will join a national effort to better understand the risks facing healthcare workers.